Terumo Announces its Application for the Manufacture and Sales Approval of its Skeletal Myoblast Sheets - To Aim for the World's First Cardiac Regenerative Therapy
Terumo transforms product portfolio of Hospital and Laboratory Business in Europe
Notice Concerning the Issuance of Stock Option (Share Warrants)
Notice Concerning the Renewal of a Policy for Large-scale Acquisitions of Terumo Shares (Takeover Defense Measures)